Testing effectiveness (Phase 2)Study completedNCT02614066
What this trial is testing
A Study Evaluating the Safety and Efficacy of Brexucabtagene Autoleucel (KTE-X19) in Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ZUMA-3)
Who this might be right for
Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia
Kite, A Gilead Company 125